ACTRN12611001268932已完成未知
For children with quiescent Crohn's disease, will a 3 month period of receiving the probiotic VSL#3, as compared to a period of 3 months receiving a placebo, prevent disease relapse
Sydney Children's Hospital0 个研究点目标入组 14 人开始时间: 2011年12月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 4 Years 至 18 Years（—）
- 性别
- All
入选标准
- •Consenting outpatients
- •Established Diagnosis of Crohn’s disease
排除标准
- •Established diagnosis of ulcerative colitis
- •Use of systemic antibiotics, other probiotics or probiotic agents within 2 weeks
- •Isolated perianal disease
- •Intend to continue concurrent administration of alternative probiotic therapy
研究者
相似试验
已完成
不适用
A Double Blind , Randomised, Placebo Controlled Trial to Determine the Efficacy of the probiotic VSL#3 in Preventing Relapse in Children with Crohn’s Disease – 12-month long term studyCrohn's diseaseOral and Gastrointestinal - Crohn's diseaseACTRN12611001267943Sydney Chidlren's hospital36
进行中（未招募）
不适用
Treatment of Crohn’s disease-associated refractory diarrhoea with octreotide LARAn open pilot studyCrohn Disease refractory diarrhoeaMedDRA version: 12.1Level: LLTClassification code 10066533Term: Diarrhea recurrentEUCTR2010-023347-14-BEGastroenterology CHC Liege
招募中
不适用
Development of Patients Reported Outcome of Crohn's disease:prospective multicenter cohort studyCrohn's diseaseJPRN-UMIN000022245Keio University School of Medicine100
招募中
不适用
Treat to target for Crohn's disease with portable bowel ultrasonographys diseaseCrohn's diseaseJPRN-UMIN000032872Tokyo Medical and Dental University200
已完成
不适用
Withdrawal of immunomodulator in Crohn's disease treated with adalimumab and immnomodulator : a multicenter randomized trial(Diamond2 study).Crohn`s diseaseJPRN-UMIN000009596Department of Internal Medicine, School of Medicine, Keio University200